Applied Genetic Technologies Corp (AGTC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

14193 NW 119TH TERRACE ALACHUA, FL 32615

Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding.

Data as of 2021-08-02 08:33:26 -0400
Market Cap153.917 Million Shares Outstanding42.755 Million Avg 30-day Volume773.237 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.04 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.76992 52-week High/Low9.67 / 3.47 Next Earnings Date2021-09-09 Price to Cash FLow (P/CF) -11.2324
Data provided by IEX Cloud
View SEC Filings from AGTC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 82 66 24.24% 27 (1.58%) 23 (1.33%) 17.39%
13F shares: 18.565 Million 14.005 Million 32.56% 8.358 Million 7.434 Million 12.43%
% Ownership 43.5211 54.0963 -19.55% 19.5926 28.7131 -31.76%
New Positions: 23 5 360.0% 10 1 900.0%
Increased Positions 38 23 65.22% 10 8 25.0%
Closed Positions 7 11 -36.36% 6 5 20.0%
Reduced Positions 12 20 -40.0% 7 9 -22.22%
Total Calls 1.1 Million 320.952 Thousand 242.61% 141.8 Thousand 45.2 Thousand 213.72%
Total Puts 225.317 Thousand 21.752 Thousand 935.84% 65.575 Thousand
PUT/CALL Ratio 0.2 0.07 185.71% 0.46 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AGTC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGTC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WASHER SUSAN B. PRESIDENT AND CEO

  • Officer
  • Director
275,000 2021-07-27 2

POTTER STEPHEN W CHIEF BUSINESS OFFICER

  • Officer
60,000 2021-07-27 4

REYNOLDS GERALD ANTHONY CHIEF ACCOUNTING OFFICER

  • Officer
25,000 2021-06-09 1

MAGOVCEVIC-LIEBISCH IVANA

  • Director
0 2020-12-16 1

HURWITZ EDWARD

  • Director
0 2020-12-16 1

KOENIG SCOTT

  • Director
0 2020-12-16 1

ROSEN JAMES

  • Director
0 2020-12-16 1

VANLENT ANNE

  • Director
0 2020-12-16 1

ALISKI WILLIAM

  • Director
0 2020-12-16 1

SHEARMAN MARK S CHIEF SCIENTIFIC OFFICER

  • Officer
33,277 2020-08-15 2

SULLIVAN WILLIAM A. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-08-05 1

KROL PATRICK JOHAN HENDRIK

STICHTING AESCAP 2.0

PRIVIUM FUND MANAGEMENT B.V.

INSPIRATIONAL VISIONS B.V.

  • 10% Owner
No longer subject to file 2019-12-26 0

KREX BRIAN GENERAL COUNSEL

  • Officer
0 2019-08-15 0

FEINSOD MATTHEW EXEC. VP, GLOBAL STRAT. & DEV.

  • Officer
No longer subject to file 2019-07-29 0

HEAH THERESA CHIEF MEDICAL OFFICER

  • Officer
0 2019-07-29 0

FEINSOD MATTHEW INTERIM CHIEF MEDICAL OFFICER

FEINSOD MATTHEW INTERIM CHIEF MEDICAL OFFICER

  • Officer
46,791 2018-12-11 0

KOENIG SCOTT

KOENIG SCOTT

  • Director
0 2018-07-25 1

BULLOCK LAWRENCE E CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2017-08-03 0

ASHE ANDREW D. GENERAL COUNSEL

  • Officer
0 2017-08-01 0

GOLDSTEIN MICHAEL H. CHIEF MEDICAL OFFICER

  • Officer
0 2017-07-17 0

ORONSKY ARNOLD L

  • Director
1,455,904 2017-04-24 0

CHULAY JEFFREY D. VP AND CHIEF MEDICAL OFFICER

  • Officer
20,400 2016-11-01 0

PEACOCK BRUCE

  • Director
0 2015-11-19 0

GLAXOSMITHKLINE PLC

  • FORMER 10% OWNER
No longer subject to file 2015-02-23 0

MENICHELLA DANIEL L V.P. & CHIEF BUSINESS OFFICER

  • Officer
0 2015-01-23 0

ALTA PARTNERS VIII, L.P.

CHAMPSI FARAH

JANNEY DANIEL

NOHRA GUY P

ALTA PARTNERS MANAGEMENT VIII, LLC

  • 10% Owner
No longer subject to file 2014-11-17 0

KNOP DAVID R. DIRECTOR, PROCESS DEVELOPMENT

  • Officer
0 2014-07-31 0

GUYER DAVID R

  • Director
0 2014-06-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

POTTER STEPHEN W - Officer CHIEF BUSINESS OFFICER

2021-07-29 17:53:45 -0400 2021-07-27 A 60,000 a 60,000 direct

WASHER SUSAN B. - Director - Officer PRESIDENT AND CEO

2021-07-29 17:41:57 -0400 2021-07-27 A 275,000 a 275,000 direct

POTTER STEPHEN W - Officer CHIEF BUSINESS OFFICER

2021-06-21 18:26:06 -0400 2021-06-17 A 35,000 a 69,677 direct 0.7246 -3.3816 4.3478 3 -3.3816 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 22:15:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 21:45:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 21:15:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 20:45:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 20:15:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 19:45:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 19:15:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 18:45:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 18:15:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 17:45:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 17:15:03 UTC -0.8357 0.8957 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 16:45:03 UTC -0.7912 0.8712 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 16:15:03 UTC -0.7912 0.8712 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 15:45:03 UTC -0.7912 0.8712 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 15:15:03 UTC -0.7912 0.8712 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 14:45:03 UTC -0.7497 0.8297 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 14:15:03 UTC -0.7497 0.8297 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 13:45:03 UTC -0.7497 0.8297 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 13:15:04 UTC -0.7497 0.8297 850000
APPLIED GENETIC TECHNOLOGIES AGTC 2021-08-02 12:45:03 UTC -0.7497 0.8297 850000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments